Back
Citius Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CTXR
Citius Pharmaceuticals, Inc.
Last Price:
$1.08
Seasonality Move:
23.69%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Sell |
| 20-day SMA: | 1.18 | Sell |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 2.3 | Sell |
Citius Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 43.85 | Sell |
| Chaikin Money Flow: | 117110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.27) | Sell |
| Bollinger Bands (100): | (1.11 - 1.45) | Sell |
Citius Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals, Inc. Stock
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 1.07 while CTXR 8-day simple moving average is 1.09, which is a Sell signal.
-
The stock price of CTXR is 1.07 while Citius Pharmaceuticals, Inc. 20-day SMA is 1.18, which makes it a Sell.
-
Citius Pharmaceuticals, Inc. 50-day simple moving average is 1.29 while CTXR share price is 1.07, making it a Sell technically.
-
CTXR stock price is 1.07 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 1.23, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
34
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Is Citius Pharmaceuticals, Inc. a Buy or a Sell?
-
Citius Pharmaceuticals, Inc. stock is rated a SellThe current Citius Pharmaceuticals, Inc. [CTXR] share price is $1.07. The Score for CTXR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals, Inc. Stock Info
Market Cap:
19.8M
Price in USD:
1.07
Share Volume:
233.6K
Citius Pharmaceuticals, Inc. 52-Week Range
52-Week High:
5.95
52-Week Low:
0.65
Sell
34
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Citius Pharmaceuticals, Inc. Share Price Forecast
-
What is the Citius Pharmaceuticals, Inc. stock price today?The Citius Pharmaceuticals, Inc. stock price is 1.07 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals, Inc. is overvalued.
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 1.07 while CTXR 8-day exponential moving average is 1.09, which is a Sell signal.
-
The stock price of CTXR is 1.07 while Citius Pharmaceuticals, Inc. 20-day EMA is 1.15, which makes it a Sell.
-
Citius Pharmaceuticals, Inc. 50-day exponential moving average is 1.22 while CTXR share price is 1.07, making it a Sell technically.
-
CTXR stock price is 1.07 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 2.30, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals, Inc.
Is Citius Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.55 per share, and an increase next year of $3.98 per share.
Technical Analysis of Citius Pharmaceuticals, Inc.
Should I short Citius Pharmaceuticals, Inc. stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Citius Pharmaceuticals, Inc. is a Sell
-
Citius Pharmaceuticals, Inc. Relative Strength Index (RSI) is 43.85, which suggest Citius Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals, Inc. is (1.01 - 1.27), which suggest Citius Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals, Inc. is (1.11 - 1.45), which suggest Citius Pharmaceuticals, Inc. is a Sell
* Citius Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.